Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

328
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
328
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

265
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
265
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

2.2K
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.2K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

1.4K
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
1.4K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

1.9K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.9K
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

431
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
431

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidence of late-onset hyperlactatemia and association with clinical outcomes in intensive care patients.

Critical care science·2025
Same author

An uncommon cause of hypophosphataemia.

Australian journal of general practice·2022
Same author

Neurodegenerative Disease Treatment Drug PBT2 Breaks Intrinsic Polymyxin Resistance in Gram-Positive Bacteria.

Antibiotics (Basel, Switzerland)·2022
Same author

A spurious decline in kidney function: A reality check.

Australian journal of general practice·2020
Same author

Anti-lipid therapy and risk factor management for triglyceridaemia-induced acute pancreatitis.

ANZ journal of surgery·2020
Same author

Discovery of glycerol phosphate modification on streptococcal rhamnose polysaccharides.

Nature chemical biology·2019

Related Experiment Video

Updated: Jan 15, 2026

Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique
08:11

Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique

Published on: November 11, 2022

3.5K

Hyperkalemia in Clinical Practice, an Important Reminder of Testing Modality.

Andrew G Turner1,2, Deepak L Vardesh1,2

  • 1Department of Perioperative Medicine Logan Hospital Meadowbrook Queensland Australia.

Clinical Case Reports
|October 13, 2025
PubMed
Summary

A patient experienced persistent hyperkalemia, complicated by acute kidney injury and pseudohyperkalemia from high platelet counts. Differentiating true from false hyperkalemia is crucial for accurate diagnosis and treatment.

Keywords:
blood gas analysisclinical chemistryhyperkalemiapseudohyperkalemiathrombocytosis

More Related Videos

Making, Testing, and Using Potassium Ion Selective Microelectrodes in Tissue Slices of Adult Brain
11:20

Making, Testing, and Using Potassium Ion Selective Microelectrodes in Tissue Slices of Adult Brain

Published on: May 7, 2018

12.7K
A Fluorescent Screening Assay for Identifying Modulators of GIRK Channels
05:31

A Fluorescent Screening Assay for Identifying Modulators of GIRK Channels

Published on: April 24, 2012

14.9K

Related Experiment Videos

Last Updated: Jan 15, 2026

Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique
08:11

Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique

Published on: November 11, 2022

3.5K
Making, Testing, and Using Potassium Ion Selective Microelectrodes in Tissue Slices of Adult Brain
11:20

Making, Testing, and Using Potassium Ion Selective Microelectrodes in Tissue Slices of Adult Brain

Published on: May 7, 2018

12.7K
A Fluorescent Screening Assay for Identifying Modulators of GIRK Channels
05:31

A Fluorescent Screening Assay for Identifying Modulators of GIRK Channels

Published on: April 24, 2012

14.9K

Area of Science:

  • Nephrology
  • Internal Medicine
  • Clinical Pathology

Background:

  • Hyperkalemia is a critical electrolyte imbalance requiring prompt recognition.
  • Distinguishing true hyperkalemia from pseudohyperkalemia is essential for appropriate patient management.
  • Thrombocytosis can artifactually elevate serum potassium levels, mimicking true hyperkalemia.

Purpose of the Study:

  • To report a case of hyperkalemia confounded by acute kidney injury and pseudohyperkalemia.
  • To highlight the diagnostic challenge posed by significant thrombocytosis in hyperkalemia assessment.
  • To emphasize the utility of comparing serum and plasma potassium levels.

Main Methods:

  • Case report detailing a patient with hyperkalemia and electrocardiogram (ECG) changes.
  • Analysis of laboratory results including serum and plasma potassium.
  • Evaluation of concurrent medical conditions, specifically acute kidney injury and thrombocytosis.

Main Results:

  • The patient presented with hyperkalemia and ECG changes, which persisted mildly after treatment.
  • True hyperkalemia due to acute kidney injury was identified.
  • Pseudohyperkalemia, attributed to marked thrombocytosis, was also present.
  • Discrepancies between serum and plasma potassium measurements confirmed pseudohyperkalemia.

Conclusions:

  • Thrombocytosis can significantly confound hyperkalemia diagnosis, leading to pseudohyperkalemia.
  • Comparing serum and plasma potassium levels is a valuable method for detecting pseudohyperkalemia.
  • Accurate differentiation between true and pseudohyperkalemia is vital for effective clinical management.